BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 32782020)

  • 1. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y; Jing L; Wang G
    J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
    Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation analysis between imaging features and lymph node metastasis in T1a lung adenocarcinoma].
    Ye B; Feng J; Pan XF; Yang Y; Geng JF; Cao KJ; Zhao H; Hu DZ
    Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):904-7. PubMed ID: 24433769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.
    Ye B; Cheng M; Ge XX; Geng JF; Li W; Feng J; Hu DZ; Zhao H
    World J Surg Oncol; 2014 Feb; 12():42. PubMed ID: 24559138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis in clinical stage IA peripheral lung cancer.
    Wang L; Jiang W; Zhan C; Shi Y; Zhang Y; Lin Z; Yuan Y; Wang Q
    Lung Cancer; 2015 Oct; 90(1):41-6. PubMed ID: 26212683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.
    Matsuguma H; Yokoi K; Anraku M; Kondo T; Kamiyama Y; Mori K; Tominaga K; Tsuura Y; Honjo S
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):278-84. PubMed ID: 12167787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter.
    Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J
    Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical Characteristics and Prognosis of Sub-centimeter Lung Adenocarcinoma].
    Mi J; Wang S; Li X; Jiang G
    Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):500-506. PubMed ID: 31451140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
    Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
    Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological characteristics and imaging features of pulmonary adenocarcinoma with micropapillary pattern].
    Ren J; Zhou J; Ding W; Zhong B; Zhou J
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):282-6. PubMed ID: 24989915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
    Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
    Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the radiological definition of part-solid tumour in lung cancer?†.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):242-247. PubMed ID: 28119328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
    Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.